Best Life: Immunotherapy targets brain cancer [Video]

CHAPEL HILL, N.C. (Ivanhoe Newswire) – Glioblastoma is the most common and aggressive form of brain tumor.

More than 14,000 people will be diagnosed with one this year and once diagnosed, most people will not live more than two years.

Despite their aggressive nature, treatments have remained the same since 2005. Now, researchers are looking at ways to make a person’s body attack the tumor.

Fran Noonan’s fingers going numb was one of the first signs something was wrong. Not long after, she was diagnosed with a glioblastoma.

“They gave me anywhere from six months to 14 months to live,” she said.

The standard of care for these types of brain tumors hasn’t changed in almost 20 years — the odds of long-term survival are slim.

“It’s about a hundred percent recurrence rate and it usually occurs around the nine-month mark,” said a Neurosurgical Oncologist at the University of North …